Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biomerieux SA finalizes acquisition of BioFire Diagnostics Inc


Thursday, 16 Jan 2014 01:15pm EST 

Biomerieux SA:Says it has finalized its acquisition of 100 pct ownership in BioFire Diagnostics Inc., a privately held U.S.-based company specialized in molecular biology.Says the agreement to purchase BioFire was first announced on Sept. 4.Says the transaction includes a $450 mln acquisition price and the company's net financial debt (around $35 mln), representing a total of 355 mln euros.Says acquisition costs will amount to six mln euros to be recorded under non-recurring items (about two mln euros in 2013 and four mln euros in 2014). 

Company Quote

77.01
-0.41 -0.53%
11:35am EDT